The p55 TNF-α receptor plays a critical role in T cell alloreactivity

Journal of Immunology

Volumn 164, Issue 2, 2000, Pages 656-663

  Hill, Geoffrey R ^a   Teshima, Takanori ^b   Rebel, Vivienne I ^a   Krijanovski, Oleg I ^a   Cooke, Kenneth R ^b   Brinson, Yani S ^a   Ferrara, James L M ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; CHROMIUM 51; CONCANAVALIN A; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; MITOGENIC AGENT; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; EXPERIMENTAL MODEL; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0034650697     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.2.656     Document Type: Article

References (46)

1. Smith, C. A., T. Farrah, and R. G. Goodwin. 1994. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 76:959.
2. Lewis, M., L. A. Tartaglia, A. Lee, G. L. Bennett, G. C. Rice, G. H. W. Wong, E. Y. Chen, and D. V. Goeddel. 1991. Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species-specific. Proc. Natl. Acad. Sci. USA 88:2830.
3. Tartaglia, L. A., R. F. Weber, I. S. Figari, C. Reynolds, M. A. Palladino, and D. V. Goeddel. 1991. The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc. Natl. Acad. Sci. USA 88:9292.
4. Tartaglia, L. A., D. V. Goeddel, C. Reynolds, I. S. Figari, R. F. Weber, B. M. Fendly, and M. A. Palladino. 1993. Stimulation of human T-cell proliferation by specific activation of the 75-kDa tumor necrosis factor-receptor. J. Immunol. 151:4637.
5. Bigda, J., I. Beletsky, C. Brakebusch, Y. Varfolomeev, H. Engelmann, J. Bigda, H. Holtmann, and D. Wallach. 1994. The dual role of the p75 tumor necrosis factor (TNF) receptor in TNF cytotoxicity. J. Exp. Med. 180:445.
6. Medvedev, A. E., A. Sundan, and T. Espevik. 1994. Involvement of the tumor necrosis factor receptor p75 in mediating cytotoxicity and gene regulating activities. Eur. J. Immunol. 24:2842.
7. Grell, M., E. Douni, H. Wajant, M. Lohden, M. Clauss, B. Maxeiner, S. Georgopoulos, W. Lesslauer, G. Kollias, K. Pfizenmaier, and P. Scheurich. 1995. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 83:793.
8. Neumann, B., A. Luz, K. Pfeffer, and B. Holzmann. 1996. Defective Peyer's patch organogenesis in mice lacking the p55 kD receptor for tumor necrosis factor. J. Exp. Med. 184:259.
9. Pasparakis, M., L. Alexopoulou, V. Episkopou, and G. Kollias. 1996. Immune and inflammatory responses in TNF α-deficient mice: a critical requirement for TNF α in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J. Exp. Med. 184:1397.
10. Erickson, S. L., F. J. de Sauvage, K. Kikly, K. Carver-Moore, S. Pitts-Meek, N. Gillett, K. C. Sheenan, R. D. Schrieber, D. V. Goeddel, and M. W. Moore. 1994. Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice. Nature 372:560.
11. Matsumoto, M., Y. X. Fu, H. Molina, G. Huang, J. Kim, D. A. Thomas, M. H. Nahm, and D. D. Chaplin. 1997. Distinct roles of lymphotoxin α and the type I tumor necrosis factor (TNF) receptor in the establishment of follicular dendritic cells from non-marrow-derived cells. J. Exp. Med. 186:1997.
12. Ngo, V. N., H. Korner, M. D. Gunn, K. N. Schmidt, D. S. Riminton, M. D. Cooper, J. L. Browning, J. D. Sedgwick, and J. G. Cyster. 1999. Lymphotoxin α/β and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T cell areas of the spleen. J. Exp. Med. 189:403.
13. Vassalli, P. 1992. The pathophsiology of tumor necrosis factors. Annu. Rev. Immunol. 10:411.
14. Sikorski, E. E., R. Hallmann, E. L. Berg, and E. C, Butcher. 1993. The Peyer's patch high endothelial receptor for lymphocytes, the mucosal vascular addressin, is induced on a murine endothelial cell line by tumor necrosis factor-α and IL-1. J. Immunol. 151:5239.
15. McKenzie, J. L., V. L. Calder, G. C. Starling, and D. N. J. Hart. 1995. Role for tumor necrosis factor-α in dendritic cell-mediated primary mixed leukocyte reactions. Bone Marrow Transplant. 15:163.
16. Page, D. M., E. M. Roberts, J. J. Peschon, and S. M. Hedrick. 1998. TNF receptor-deficient mice reveal striking differences between several models of thymocyte negative selection. J. Immunol. 160:120.
17. Pfeffer, K., T. Matsuyama, T. M. Kundig, A. Wakeham, K. Kishihara, A. Shahinian, K. Wiegmann, P. S. Ohashi, M. Kronke, and T. W. Mak. 1993. Mice deficient for the 55kD tumor necrosis factor receptor are resistant to endotoxin shock, yet succumb to L. monocytogenes infection. Cell 73:457.
18. Peschon, J. J., D. S. Torrance, K. L. Stocking, M. B. Glaccum, C. Otten, C. R. Willis, K. Charrier, P. J. Morrissey, C. B. Ware, and K. M. Mohler. 1998. TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation. J. Immunol. 160:943.
19. Hill, G. R., J. M. Crawford, K. J. Cooke, Y. S. Brinson, L. Pan, and J. L. M. Ferrara. 1997. Total body irradiation and acute graft versus host disease: the role of gastrointestinal damage and inflammatory cytokines. Blood 90:3204.
20. Hill, G. R., K. R. Cooke, T. Teshima, J. M. Crawford, J. C. J. Keith, Y. S. Brinson, D. Bungard, and J. L. M. Ferrara. 1998. Interleukin-11 promotes T cell polarization and prevents acute graft-versus-host disease after allogeneic bone marrow transplantation. J. Clin. Invest, 102:115.
21. Cooke, K. R., L. Kobzik, T. R. Martin, J. Brewer, J. Delmonte, J. M. Crawford, and J. L. M. Ferrara. 1996. An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation. 1. The roles of minor H antigens and endotoxin. Blood 88:3230.
22. Teshima, T., G. R. Hill, L. Pan, Y. S. Brinson, M. R. M. van den Brink, K. R. Cooke, and J. L. M. Ferrara. 1999. Interleukin-11 improves separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantation. J. Clin. Invest. 104:317.
23. Rieckmann, P., F. D'Alessandro, R. F. Nordan, A. S. Fauci, and J. H. Kehrl. 1991. IL-6 and tumor necrosis factor-α: Autocrine and paracrine cytokines involved in B cell function. J. Immunol. 146:3462.
24. Jelinek, D. F., and P. E. Lipsky. 1987. Enhancement of human B cell proliferation and differentiation by tumor necrosis factor-α and interleukin-1. J. Immunol. 139:2970.
25. Yokota, S., T. D. Geppert, and P. E. Lipsky. 1988. Enhancement of antigen- and mitogen-induced human T lymphocyte proliferation by tumor necrosis factor-α. J. Immunol. 140:531.
26. Rebel, V. I., S. Hartnett, G. R. Hill, S. B. Lazo-Kallanian, J. L. M. Ferrara, and C. A. Sieff. 1999. Essential role for the p55 TNF receptor in regulating hematopoiesis at a stem cell level. J. Exp. Med. 190:1493.
27. Hill, G. R., W. Krenger, and J. L. M. Ferrara. 1997. Cytokine dysregulation in acute graft-versus-host disease. Hematology 2:423.
28. Becher, B., M. Blain, P. S. Giacomini, and A. J.P. 1999. Inhibition of Th1 polarization by soluble TNF receptor is dependent on antigen-presenting cell-derived IL-12. J. Immunol. 162:684.
29. Welborn, M. B., III, K. Van Zee, P. D. Edwards, J. H. Pruitt, A Kaibara, J. Vauthey, M. Rugy, W. L. Castleman, S. F. Lowry, J. S. Kenney, et al. 1996. A human tumor necrosis factor p75 receptor stimulates in vitro T cell proliferation but does not produce inflammatory or shock in baboon. J. Exp. Med. 184: 165.
30. Grell, M., F. M. Beck, H. Wajant, D. N. Mannel, and P. Scheurich. 1998. TNF receptor type 2 mediates thymocyte proliferation independently of TNF receptor type 1. Eur. J. Immunol. 28:257.
31. Pimentel-Muinos, F. X., M. A. Munoz-Fernandez, and M. Fresno. 1994. Control of T lymphocyte actvation and IL-2 receptor expression by endogenously secreted cytokines. J. Immunol. 152:5714.
32. Zheng, L., G. Fisher, R. E. Miller, J. Peshon, D. H. Lynch, and M. J. Lenardo. 1995. Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 377:348.
33. Speiser, D. E., E. Sebzda, T. Ohteki, M. F. Bachmann, K. Pfeffer, T. W. Mak, and P. S. Ohashi. 1996. Tumor necrosis factor receptor p55 mediates deletion of peripheral cytotoxic T lymphocytes in vivo. Eur. J. Immunol. 26:3055.
34. Sarin, A., M. Conan-Cibotti, and P. A. Henkart. 1995. Cytotoxic effect of TNF and lymphotoxin on T lymphoblasts. J. Immunol. 155:3716.
35. Vella, A. T., J. E. McCormack, P. S. Linsley, J. W. Kappler, and P. Marrack. 1995. Lipopolysaccharide interferes with the induction of peripheral T cell death. Immunity 2:261.
36. Vella, A. T., T. Mitchell, B. Groth, P. S. Linsley, J. M. Green, C. B. Thompson, J. W. Kappler, and P. Marrack. 1997. CD28 Engagement and proinflammatory cytokines contribute to T cell expansion and long term survival in vivo. J. Immunol. 158:4714.
37. Byrne, J. A., J. L. Butler, E. L. Reinherz, and M. D. Cooper. 1989. Differential activation requirements for virgin and memory T cells. J. Immunol. 141:3249.
38. + T cells cannot be overcome by CD28 costimulation. Eur. J. Immunol 24:1956.
39. Farber, D. L., M. Luqman, O. Acuto, and Bottomly. 1995. Control of memory CD4 T cell activation: MHC class II molecules on APCs and CD4 ligation inhibit memory but not naive CD4 T cells. Immunity 2:249.
40. Robinet, E., D. Branellec, A. M. Termijtelen, J. Y. Blay, F. Gay, and S. Chouaib. 1990. Evidence for tumor necrosis factor-α involvement in the optimal induction of class I allospecific cytotoxic T cells. J. Immunol. 144:4555.
41. Hill, G. R., T. Teshima, A. Gerbita, L. Pan, K. R. Cooke, Y. S. Brinson, J. M. Crawford, and J. L. M. Ferrara. 1999. Differential Roles of IL-1 and TNFα on graft-versus-host disease and graft-versus-leukemia. J. Clin. Invest. 104:459.
42. Tsukada, N., T. Kobata, Y. Aivawa, H. Yagita, and K. Okumura. 1999. Graft-versus-leukemia effect and graft-versus-host disease can be differentiated by cytotoxic mechanisms in a murine model of bone marrow transplantation. Blood 93:2738.
43. Lichtman, A., W. Krenger, and J. L. M. Ferrara. 1997. Cytokine networks In Graft-Versus-Host Disease. 2nd Ed. J. L. M. Ferrara, H. J. Deeg, and S. J. Burakoff, eds. M. Dekker, New York, p. 179.
44. Cooke, K. R., G. R. Hill, J. M. Crawford, D. Bungard, Y. Brinson, J. Delmonte, and J. L. M. Ferrara. 1998. TNFα production to LPS stimulation by donor cells predicts the severity of experimental acute graft-versus-host disease. J. Clin. Invest. 102:1882.
45. Speiser, D. E., M. F. Bachmann, T. W. Frick, K. McKall-Faienza, E. Griffiths, K. Pfeffer, T. W. Mak, and P. S. Ohashi. 1997. TNF receptor p55 controls early graft-versus-host disease. J Immunol. 158:5185.
46. Nestel, F. P., K. S. Price, T. A. Seemayer, and W. S. Lapp. 1992. Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor α during graft-versus-host disease. J. Exp. Med. 175:405.